These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 33532947)
1. Biomarkers of disease severity in vivax malaria. Aqeel S; Naheda A; Raza A; Khan W Parasitol Res; 2021 Apr; 120(4):1437-1446. PubMed ID: 33532947 [TBL] [Abstract][Full Text] [Related]
2. Oxidative stress in vivax malaria. Bilgin R; Yalcin MS; Yucebilgic G; Koltas IS; Yazar S Korean J Parasitol; 2012 Dec; 50(4):375-7. PubMed ID: 23230340 [TBL] [Abstract][Full Text] [Related]
3. Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity. Andrade BB; Reis-Filho A; Souza-Neto SM; Raffaele-Netto I; Camargo LM; Barral A; Barral-Netto M PLoS Negl Trop Dis; 2010 Apr; 4(4):e650. PubMed ID: 20386593 [TBL] [Abstract][Full Text] [Related]
4. Lipid peroxidation and antioxidant enzymes activity in Plasmodium vivax malaria patients evolving with cholestatic jaundice. Fabbri C; de Cássia Mascarenhas-Netto R; Lalwani P; Melo GC; Magalhães BM; Alexandre MA; Lacerda MV; Lima ES Malar J; 2013 Sep; 12():315. PubMed ID: 24020374 [TBL] [Abstract][Full Text] [Related]
5. Screening and identification of potential novel biomarker for diagnosis of complicated Plasmodium vivax malaria. Kaur H; Sehgal R; Kumar A; Sehgal A; Bansal D; Sultan AA J Transl Med; 2018 Oct; 16(1):272. PubMed ID: 30286756 [TBL] [Abstract][Full Text] [Related]
6. A prospective study from south India to compare the severity of malaria caused by Plasmodium vivax, P. falciparum and dual infection. Mitra S; Abhilash K; Arora S; Miraclin A J Vector Borne Dis; 2015 Dec; 52(4):281-6. PubMed ID: 26714506 [TBL] [Abstract][Full Text] [Related]
7. Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax. Guedes KS; Sanchez BAM; Gomes LT; Fontes CJF PLoS One; 2019; 14(11):e0224877. PubMed ID: 31765438 [TBL] [Abstract][Full Text] [Related]
8. Severe vivax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India. Matlani M; Kojom LP; Mishra N; Dogra V; Singh V Ann Clin Microbiol Antimicrob; 2020 Oct; 19(1):49. PubMed ID: 33126884 [TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in patients with non-complicated malaria. Pabón A; Carmona J; Burgos LC; Blair S Clin Biochem; 2003 Feb; 36(1):71-8. PubMed ID: 12554064 [TBL] [Abstract][Full Text] [Related]
10. Population-level estimates of the proportion of Plasmodium vivax blood-stage infections attributable to relapses among febrile patients attending Adama Malaria Diagnostic Centre, East Shoa Zone, Oromia, Ethiopia. Golassa L; White MT Malar J; 2017 Jul; 16(1):301. PubMed ID: 28750669 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Analysis and Multipronged Quantitative Proteomics Reveal Oxidative Stress and Cytoskeletal Proteins as Possible Markers for Severe Vivax Malaria. Ray S; Patel SK; Venkatesh A; Bhave A; Kumar V; Singh V; Chatterjee G; Shah VG; Sharma S; Renu D; Nafis N; Gandhe P; Gogtay N; Thatte U; Sehgal K; Verma S; Karak A; Khanra D; Talukdar A; Kochar SK; S B V; Kochar DK; Rojh D; Varma SG; Gandhi MN; Srikanth R; Patankar S; Srivastava S Sci Rep; 2016 Apr; 6():24557. PubMed ID: 27090372 [TBL] [Abstract][Full Text] [Related]
12. Microscopic and molecular evidence of the presence of asymptomatic Plasmodium falciparum and Plasmodium vivax infections in an area with low, seasonal and unstable malaria transmission in Ethiopia. Golassa L; Baliraine FN; Enweji N; Erko B; Swedberg G; Aseffa A BMC Infect Dis; 2015 Aug; 15():310. PubMed ID: 26242405 [TBL] [Abstract][Full Text] [Related]
14. Retinopathy of vivax malaria in adults and its relation with severity parameters. Kochar A; Kalra P; Sb V; Ukirade V; Chahar A; Kochar DK; Kochar SK Pathog Glob Health; 2016; 110(4-5):185-93. PubMed ID: 27533797 [TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of vivax malaria patients presenting to tertiary referral centre of Uttarakhand. Srivastava S; Ahmad S; Shirazi N; Kumar Verma S; Puri P Acta Trop; 2011 Feb; 117(2):82-5. PubMed ID: 20943199 [TBL] [Abstract][Full Text] [Related]
16. Severe vivax malaria: a prospective exploration at a tertiary healthcare centre in Southwestern India. Kumar R; Saravu K Pathog Glob Health; 2017 May; 111(3):148-160. PubMed ID: 28367735 [TBL] [Abstract][Full Text] [Related]
17. Multiplicity of Infection and Disease Severity in Plasmodium vivax. Pacheco MA; Lopez-Perez M; Vallejo AF; Herrera S; Arévalo-Herrera M; Escalante AA PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004355. PubMed ID: 26751811 [TBL] [Abstract][Full Text] [Related]
18. Oxidative stress of platelets and thrombocytopenia in patients with vivax malaria. Erel O; Vural H; Aksoy N; Aslan G; Ulukanligil M Clin Biochem; 2001 Jun; 34(4):341-4. PubMed ID: 11440737 [TBL] [Abstract][Full Text] [Related]
19. How benign is benign tertian malaria? Sharma A; Khanduri U J Vector Borne Dis; 2009 Jun; 46(2):141-4. PubMed ID: 19502694 [TBL] [Abstract][Full Text] [Related]
20. Severe Plasmodium vivax infection in Korea. Im JH; Kwon HY; Baek J; Park SW; Durey A; Lee KH; Chung MH; Lee JS Malar J; 2017 Jan; 16(1):51. PubMed ID: 28129766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]